Australia’s active vaccine safety system

AusVaxSafety is conducting active vaccine safety surveillance of recently introduced respiratory syncytial virus (RSV) vaccines in Australia to ensure their ongoing safety.

The RSV vaccines registered for use in Australia are:

  • Arexvy® – registered for use in adults aged 60 years and over
  • Abrysvo® – registered for use in pregnant people and adults aged 60 years and over.

Safety data are gathered via the AusVaxSafety surveillance program and are based on vaccine safety surveys sent in the days following RSV vaccination. Data on this page are updated monthly.

Latest RSV vaccine safety data

Click on the tiles below to view AusVaxSafety RSV vaccine safety data for specific age and population groups.

Note: Vaccine safety data for additional population groups and other RSV vaccines will be added once enough data are collected to enable meaningful analysis.